Sexual Function in Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 14, Issue 2, 2007, Pages 119-125

  Anantharaman, Priya ^a   Schmidt, Rebecca J ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

end stage renal disease; hormone replacement therapy; hypogonadism; prolactin; Sexual dysfunction; sildenafil

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CALCITRIOL; CIMETIDINE; CLOMIFENE CITRATE; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; LISURIDE; METOCLOPRAMIDE; NANDROLONE; PHENOTHIAZINE; PROGESTERONE; RECOMBINANT ERYTHROPOIETIN; SILDENAFIL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DEPRESSION; DIALYSIS; DISEASE EXACERBATION; ERECTILE DYSFUNCTION; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; HYPERPARATHYROIDISM; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPOTENCE; KIDNEY FAILURE; LIBIDO DISORDER; LIVER TOXICITY; MALE INFERTILITY; MALE SEXUAL DYSFUNCTION; MENSTRUATION DISORDER; METABOLIC DISORDER; MINERAL METABOLISM; POLYCYTHEMIA; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; RISK FACTOR; SIDE EFFECT; SLEEP APNEA SYNDROME; SYMPTOM; UREMIA;

ANDROGENS; CHRONIC DISEASE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SULFONES; TESTOSTERONE;

EID: 33947535416     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2007.01.002     Document Type: Article

References (48)

1. Palmer B.F. Sexual dysfunction in uremia. J Am Soc Nephrol 10 (1999) 1381-1388
2. Holley J.L., Schmidt R.J., Bender F., et al. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 29 (1997) 685-690
3. Chryssicopoulos A., Koutsikos D., Kapetanski A., et al. Evaluation of the hypothalamic-pituitary axis in uremic males using dynamic tests: the possible role of testicular inhibin: A preliminary report. Ren Fail 19 (1996) 911-921
4. Handelsman D.J., and Dong Q. Hypothalamic-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 22 (1993) 145-161
5. Lim V.S., Henriquez C., Dieversten G., et al. Ovarian function in chronic renal failure. Evidence of hypothalamic anovulation. Ann Intern Med 93 (1980) 21-27
6. Perez R.J., Lipner H., Abdulla N., et al. Menstrual dysfunction of patients undergoing hemodialysis. Obstet Gynecol 51 (1978) 552-555
7. Schmidt R.J., and Holley J.L. Fertility and contraception in end stage renal disease. Adv Ren Replace Ther 5 (1998) 38-44
8. Leavey S.F., and Weitzel W.F. Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am 31 (2002) 107-119
9. Holley J.L., and Reddy S.S. Pregnancy in dialysis patients: A review of outcomes, complications, and management. Semin Dial 16 (2003) 384-388
10. Okundaye I., Abrinko P., and Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis 31 (1998) 766-773
11. Sturgiss S.N., and Davidson J.M. Effect of pregnancy on long-term function of renal allografts. Am J Kidney Dis 19 (1992) 167-172
12. Holley J.L., Schmidt R.J., Bender F., et al. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 29 (1997) 685-690
13. Stewart-Bentley M., Gans D., and Horton R. Regulation of gonadal function in uremia. Metabolism 23 (1974) 1065-1072
14. Palmer B.F. Outcomes associated with hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Dis 11 (2004) 342-347
15. Lim V., Kathpalia S.C., and Frohman L.A. Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: Reversal after transplantation. J Clin Endocrinol Metab 48 (1979) 101-107
16. Hou S.H., Grossman S., and Molitch M.E. Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or continuous ambulatory peritoneal dialysis. Am J Kidney Dis 6 (1985) 245-249
17. Weisinger J.R., and Bellorin-Font E. Outcomes associated with hypogonadism in women with chronic kidney disease. Adv Chronic Kidney Dis 11 (2004) 361-370
18. Gipson D., Katz L.A., and Stehman-Breen C. Principles of dialysis: Special issues in women. Semin Nephrol 19 (1999) 140-147
19. Toorians A.W., Janssen E., Laan E., et al. Chronic renal failure and sexual functioning: Clinical status versus objectively assessed sexual response. Nephrol Dial Transplant 12 (1997) 2654-2663
20. Nappi R.E., Wawra L., and Schmitt S. Hypoactive sexual desire disorder in postmenopausal women. Gynecol Endocrinol 22 (2006) 318-323
21. Milde F.K., Hart L.K., and Fearing M.O. Sexuality and fertility concerns of dialysis patients. ANNA J 23 (1996) 307-313
22. Raiz L., Davies E.A., and Ferguson R.M. Sexual functioning following renal transplantation. Health Soc Work 28 (2003) 264-272
23. Matuszkiewicz-Rowinska J., Skorzewska K., Radowicki S., et al. The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis. Nephrol Dial Transplant 14 (1999) 1238-1242
24. Holley J.L., and Schmidt R.J. Hormone replacement therapy in postmenopausal women with end stage renal disease: A review of the issues. Semin Dial 14 (2001) 146-149
25. Davis S.R., van der Mooren M.J., van Lunsen R.H., et al. Efficacy and safety of testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Menopause 13 (2006) 387-396
26. Simon J., Braunstein G., Nachtigall L., et al. Testosterone patch increases sexual activity and desire in surgically menopausal wimen with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90 (2005) 5226-5233
27. Berman J.R., Berman L.A., Toler S.M., et al. Safety and efficacy of sidenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol 170 (2003) 2333-2338
28. Palmer B.F. Sexual dysfunction in men and women with chronic kidney disease and end-stage renal disease. Adv Ren Replace Ther 10 (2003) 48-60
29. de Francisco A.L., Fernandez Fresnedo G., and Rodrigo E. Past, present and future of erythropoietin use in the elderly. Int Urol Nephrol 33 (2002) 187-193
30. Kokot F., Wicek A., Schmidt-Gayk H., et al. Function of endocrine organs in hemodialysis patients of long term erythropoietin therapy. Artif Organs 19 (1995) 428-435
31. Schaefer F., van Kaick B., Veldhuis J.D., et al. Changes in the kinetics and biopotency of lutinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. J Am Soc Nephrol 5 (1994) 1208-1215
32. Johansen K.L. Treatment of hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Dis 4 (2004) 348-356
33. Meikle A., Mazer N., Moellmer J., et al. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. J Clin Endocrinol Metab 74 (1992) 623-628
34. Meikle A., Arver S., Dobs A., et al. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: Influence of application site-A clinical research center study. J Clin Endocrinol Metab 81 (1996) 1832-1840
35. Wang C., Swedloff R., Iranmanesh A., et al. Transdermal testosterone gel improves sexual function, mood, muscle strength and body composition parameters in hypogonadal men. Testosterone gel study group. J Clin Endocrinol Metab 85 (2000) 2839-2853
36. Morley J., Perry III H., Kaiser F., et al. Effect of testosterone replacement therapy in older hypogonadal males: A preliminary study. J Am Geriatr Soc 41 (1993) 149-152
37. Wu F., and Eckardstein A.V. Androgens and coronary artery disease. Endocr Rev 24 (2003) 183-217
38. Rosas S.E., Wasserstein A., Kobrin S., et al. Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients. Am J Kidney Dis 37 (2001) 134-137
39. Chen J., Mabjeesh N.J., Greenstein A., et al. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol 165 (2001) 819-821
40. Barrou B., Cuzin B., Malavaud B., et al. Early experience with sildenafil for the treatment of erectile dysfunction in renal transplant recipients. Nephrol Dial Transplant 18 (2003) 411-417
41. Turk S., Karalezli G., Tonbul H.Z., et al. Erectile dysfunction and the effects of sildenafil treatment in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 16 (2001) 1818-1822
42. Ghahramani N., Behzadi A., Gholami S., et al. Post renal transplant improvement of sexual function. Transplant Proc 31 (1999) 3144
43. Tsujimura A, Matsumiya K, Tsuboniwa N, et al: Effect of renal transplantation on sexual function. Arch Androl 48:467-474, 1002
44. Saha M.T., Saha H.H., Niskanen L.K., et al. Time course of serum prolactin and sex hormones following successful renal transplantation. Nephron 92 (2002) 735-737
45. Pietrzak B., Wielgos M., Kaminski P., et al. Menstrual cycle and sex hormone profile in kidney-transplanted women. Neuro Endocrinol Lett 27 (2006) 198-202
46. Akbari F., Alavi M., Esteghamath A., et al. Effects of renal transplantation on sperm quality and sex hormone levels. Br J Urol 92 (2003) 281-283
47. Kantarci G., Sahin S., Uras A.R., et al. Effects of different calcineurin inhibitors on sex hormone levels in transplanted male patients. Transplant Proc 35 (2004) 178-179
48. Diemont W.L., Vruffink P.A., Mueleman E.I.H., et al. Sexual function after renal replacement therapy. Am J Kidney Dis 35 (2000) 845-851